Add to a list

Inactive Instrument

Misonix, Inc. Share Price

MSON

US6048711039

Medical Equipment, Supplies & Distribution

on all subscriptions*

Last days

Enjoy this offer

* See conditions under "Our services"

Analysts' recommendations: Misonix, Inc.

02/21/02	MISONIX : BTIG Downgrades Misonix to Neutral From Buy	MT
30/21/30	MISONIX : Craig-Hallum Downgrades Misonix to Hold From Buy; Price Target is $28	MT
30/21/30	MISONIX : Canaccord Genuity Downgrades Misonix to Hold From Buy; Price Target is $28	MT

More recommendations

Managers and Directors: Misonix, Inc.

Manager	Title	Age	Since
John Joseph Salerno CMP	Compliance Officer	70	01/03/2015
Daniel Voic CTO	Chief Tech/Sci/R&D Officer	63	01/01/2002

More insiders

Misonix, Inc. (Misonix), is a medical devices company. The Company is engaged in designing, manufacturing and marketing of minimally invasive therapeutic ultrasonic medical devices. Its products include BoneScalpel Surgical System (BoneScalpel), SonicOne Wound Cleansing and Debridement System (SonicOne) and SonaStar Surgical Aspirator (SonaStar). BoneScalpel is used for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue. SonaStar is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery field. SonicOne offers tissue specific debridement and cleansing of wounds and burns for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The Company's products are nexus, BoneScalpel, SonaStar, SonicOne, TheraSkin and Therion.

Employees

281

Sector

Medical Equipment, Supplies & Distribution

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
MSON Stock

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrows Top Investments!

SEIZE THE OFFER!

26/22/26	Misonix, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021	CI
01/21/01	Misonix, Inc.(NasdaqGM:MSON) dropped from S&P TMI Index	CI
01/21/01	Misonix, Inc.(NasdaqGM:MSON) dropped from S&P Global BMI Index	CI
29/21/29	Misonix, Inc.(NasdaqGM:MON) dropped from NASDAQ Composite Index	CI
29/21/29	Bioventus Inc. completed the acquisition of Misonix, Inc. from Stavros G. Vizirgianakis, SV Life Sciences Fund VI, L.P. and Sv Life Sciences Fund VI Strategic Partners, L.P., funds managed by SV Health Investors, LLC, 1315 Capital, LLC and others.	CI
03/21/03	Misonix : Q4 Net Loss Narrows, Revenue Surges	MT
03/21/03	Misonix : Earnings Flash (MSON) MISONIX Posts Q4 Revenue $19.7M	MT
03/21/03	Misonix, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2021	CI
13/21/13	Misonix, Inc. Announces Nonrenewal of Allan Staley as President and Named Executive Officer	CI
02/21/02	MISONIX : BTIG Downgrades Misonix to Neutral From Buy	MT
31/21/31	Misonix : Bioventus to Acquire Misonix in Cash-and-Stock Deal Valued at $518 Million	MT
30/21/30	NASDAQ 100 : Top Midday Gainers	MT
30/21/30	MISONIX : Craig-Hallum Downgrades Misonix to Hold From Buy; Price Target is $28	MT

30/21/30	MISONIX INC : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
27/21/27	MISONIX INC : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
19/21/19	MISONIX INC : Other Events (form 8-K)	AQ
03/21/03	MISONIX : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
03/21/03	MISONIX : REPORTS FOURTH QUARTER AND FISCAL YEAR 2021 FINANCIAL RESULTS (Form 8-K)	PU

Date	Insider	Type	Main position	Quantity	% Market Cap.
29/21/29	Thomas Patton	Issuer sale	Director	1,04,500	0.5997%
29/21/29	Stavros Vizirgianakis	Issuer sale	Chief Executive Officer	21,36,478	12.2610%
29/21/29	Joseph P. Dwyer	Issuer sale	Chief Financial Officer	2,76,200	1.5851%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MISONIX, INC.	+4.74%	+2.95%	-	-	46Cr
PENUMBRA, INC.	+0.06%	-0.67%	+25.65%	-2.97%	1.25TCr
ASAHI INTECC CO., LTD.	-4.84%	-3.12%	+54.12%	+34.63%	631.56Cr
GETINGE AB	+4.08%	+0.98%	+4.53%	-20.55%	538.19Cr
MINIMED GROUP, INC.	-0.29%	+8.68%	-	-	434.43Cr
APT MEDICAL INC.	+2.67%	+3.00%	-27.08%	+21.07%	415.86Cr
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+2.53%	+0.08%	-29.26%	-20.95%	373.02Cr
NOVOCURE LIMITED	+1.30%	+4.60%	-1.37%	-59.42%	205.12Cr
IMPLANTICA AG	+5.23%	+3.92%	+42.54%	+195.34%	164.5Cr
NAKANISHI INC.	-2.11%	+2.31%	+57.77%	+2.06%	159.38Cr
Average	+1.35%	+1.36%	+15.86%	+18.65%	463.78Cr
Weighted average by Cap.	+0.52%	+1.17%	+16.71%	+7.57%

Misonix, Inc. Share Price

Stocks

MSON

US6048711039

Medical Equipment, Supplies & Distribution

Latest news : Misonix, Inc.

Analysts' recommendations: Misonix, Inc.

Press Releases: Misonix, Inc.

Quotes and Performance

Managers and Directors: Misonix, Inc.

Latest insider transactions

Medical Equipment

Company Profile